Home › Funds › Renaissance Technologies › EBS

Renaissance Technologies position in EBS

EMERGENT BIOSOLUTIONS INC · Health Care

Latest position (Q2 2026)683.25K sh
Reported value held$5.73M
Portfolio Weight0.01%
First reportedQ1 2022
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q1 2022 358.00K $14.70M New
Q2 2022 95.00K $2.95M Reduce
Q3 2022 55.10K $1.16M Reduce
Q4 2022 304.00K $3.59K Add
Q4 2023 547.30K $1.31K New
Q1 2024 891.30K $2.25K Add
Q2 2024 173.75K $1.18M Reduce
Q3 2024 524.95K $4.38M Add
Q4 2024 665.85K $6.37M Add
Q1 2025 760.25K $3.69M Add
Q1 2025 760.25K $3.69M Add
Q2 2025 689.65K $4.40M Reduce
Q2 2025 689.65K $4.40M Reduce
Q3 2025 518.25K $4.57M Reduce
Q4 2025 577.15K $7.13M Add
Q1 2026 656.05K $5.45M Add
Q2 2026 683.25K $5.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding EBS

All EBS fund holders →